Effective & Efficient Surfactant Therapy Management on Neonatal outcomes in Newborn Intensive care unit (NICU) at Mehta Multi Speciality Hospitals, a Tertiary care Centre, Chennai, Tamil Nadu, India.

Venkatesan Murugan1, Udhaya Rani B2

Mehta Multi Speciality Hospitals India Pvt Ltd, Chennai, Tamilnadu, India

INTRODUCTION

Respiratory distress syndrome (RDS) is primarily due to surfactant deficiency in preterm infants. Surfactant treatment is the standard of care in preterm neonates with RDS. Surfactant therapy has been shown to decrease pneumothorax, BPD, Pulmonary hemorrhage with clinical deterioration, improve oxygenation and reduce the need for extracorporeal membrane oxygenation (ECMO), thus  improving newborn survival. Timing of surfactant administration is one of the important Criteria to be considered. Recent evidence still demonstrates that early rescue surfactant (first 2 hours of age) versus late rescue surfactant (After 2 hours of age) is associated with a reduction in BPD and/or death. Therefore, the American Academy of Pediatrics and the European guidelines on surfactant administration advise stabilization of preterm infants on CPAP and, if necessary, the administration of surfactant as early rescue therapy, preferably within 2- 3 hours of age

Aim

Effective & Efficient Surfactant Therapy Management to improve Neonatal outcomes in Newborn Intensive care unit (NICU)

Objectives